Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes

Diabetic Medicine

Volumn 18, Issue 8, 2001, Pages 619-625

  Witthaus, E ^a   Stewart, J ^b   Bradley, C ^c  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b Aventis Pharma   (Canada)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Insulin glargine; NPH insulin; Psychological well being; Treatment satisfaction; Type 1 diabetes

Indexed keywords

INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIABETES TREATMENT SATISFACTION QUESTIONNAIRE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SYRINGE; VARIANCE; WELLBEING; WELLBEING QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN, ISOPHANE; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0034844927     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00529.x     Document Type: Article

References (22)

1. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus
2. Well-being and treatment satisfaction in older people with diabetes
3. The Diabetes Treatment Satisfaction Questionnaire: DTSQ
4. New insulin preparations with prolonged action profiles: A21-modified arginine insulins
5. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes
6. Comparative clinical trial of a new long-acting insulin (HOE 901) vs. protamine insulin demonstrates less nocturnal hypoglycaemia
7. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes
8. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in Type 2 diabetes
9. The Well-being Questionnaire
10. Psychometric evaluation of the Diabetes Treatment Satisfaction Questionnaire in 8 languages
11. Evaluating the 12-item Well-being Questionnaire for use in multinational trials
12. Preferences for, and improvements in aspects of quality of life (QoL) with insulin lispro in a multiple injection regimen
13. Guidelines for encouraging psychological well-being: Report of a Working Group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St. Vincent Declaration Action Programme for Diabetes
14. Effect sizes for interpreting changes in health status
15. Insulin lispro changes treatment satisfaction under flexible, functional insulin treatment
16. Randomised controlled trial of patient-centred care in general practice: Impact on current well-being and future disease risk
17. Use of insulin lispro in continuous subcutaneous insulin infusion treatment
18. Measuring quality of life in diabetes
19. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire (DTSQ)
20. Diabetes Treatment Satisfaction Questionnaire: Change version for use alongside status version provides appropriate solution where ceiling effects occur
21. On calculating treatment satisfaction
22. Response to Bradley